KR100317901B1 - A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism - Google Patents
A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism Download PDFInfo
- Publication number
- KR100317901B1 KR100317901B1 KR1019990053494A KR19990053494A KR100317901B1 KR 100317901 B1 KR100317901 B1 KR 100317901B1 KR 1019990053494 A KR1019990053494 A KR 1019990053494A KR 19990053494 A KR19990053494 A KR 19990053494A KR 100317901 B1 KR100317901 B1 KR 100317901B1
- Authority
- KR
- South Korea
- Prior art keywords
- glutamic acid
- strain
- microorganism
- present
- medium
- Prior art date
Links
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 235000013922 glutamic acid Nutrition 0.000 title claims abstract description 22
- 239000004220 glutamic acid Substances 0.000 title claims abstract description 22
- 244000005700 microbiome Species 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 235000000346 sugar Nutrition 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 10
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000008103 glucose Substances 0.000 claims abstract description 10
- 235000013379 molasses Nutrition 0.000 claims abstract description 10
- 241000186226 Corynebacterium glutamicum Species 0.000 claims abstract description 7
- 239000002699 waste material Substances 0.000 claims abstract description 4
- 229920002472 Starch Polymers 0.000 claims abstract description 3
- 239000008107 starch Substances 0.000 claims abstract description 3
- 235000019698 starch Nutrition 0.000 claims abstract description 3
- 235000001727 glucose Nutrition 0.000 claims abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
- 238000012258 culturing Methods 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 238000007796 conventional method Methods 0.000 abstract description 3
- 230000037353 metabolic pathway Effects 0.000 abstract description 3
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 abstract description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 18
- 239000002609 medium Substances 0.000 description 17
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 15
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 14
- 238000000855 fermentation Methods 0.000 description 14
- 230000004151 fermentation Effects 0.000 description 14
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
- 238000011218 seed culture Methods 0.000 description 10
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 10
- 239000004202 carbamide Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 7
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 7
- 235000011130 ammonium sulphate Nutrition 0.000 description 7
- 229910000358 iron sulfate Inorganic materials 0.000 description 7
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- 229940099596 manganese sulfate Drugs 0.000 description 7
- 239000011702 manganese sulphate Substances 0.000 description 7
- 235000007079 manganese sulphate Nutrition 0.000 description 7
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 7
- 229960000344 thiamine hydrochloride Drugs 0.000 description 7
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 7
- 239000011747 thiamine hydrochloride Substances 0.000 description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 7
- 229960002685 biotin Drugs 0.000 description 6
- 235000020958 biotin Nutrition 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- 239000002207 metabolite Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 4
- 235000013882 gravy Nutrition 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000005415 magnetization Effects 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 229910000160 potassium phosphate Inorganic materials 0.000 description 4
- 235000011009 potassium phosphates Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 3
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- -1 acetic acid analog monofluoroacetate Chemical class 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/14—Glutamic acid; Glutamine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/15—Corynebacterium
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 글루탐산을 생산하는 코리네박테리움 글루타미컴 (Corynebacterium glutamicum) KFCC-10656을 모균주로 자외선조사, N-메틸-N`-니트로-N-니트로소구아니딘 (NTG) 등의 변이 유발제로 통상적인 방법에 따라 처리하여 모균주의 형질을 변형시켜, 모노플루오로아세테이트 내성을 가지게 함으로써 균주의 대사경로에 변화가 생겨서, 모균주에 비해 글루탐산 생산능력이 향상된 변이주에 관한 것이다. 또한 이 변이주를 폐당밀, 포도당, 전분 가수분해물 및 원당 등이 포함된 배지중에서 배양하여 배양물로부터 글루탐산을 채취하는, 미생물을 이용한 글루탐산의 제조방법에 관한 것이다.The present invention is directed to mutant causing agents such as UV irradiation, N-methyl-N`-nitro-N-nitrosoguanidine (NTG), as a parent strain of Corynebacterium glutamicum , which produces glutamic acid, as a parent strain. The present invention relates to a mutant strain having a change in the metabolic pathway of the strain by modifying the strain of the parent strain to have monofluoroacetate resistance by treatment according to a conventional method, thereby improving the glutamic acid production capacity as compared with the parent strain. The present invention also relates to a method for producing glutamic acid using microorganisms, wherein the mutant strain is cultured in a medium containing waste molasses, glucose, starch hydrolyzate, raw sugar, and the like to extract glutamic acid from the culture.
Description
본 발명은 글루탐산을 생산하는 미생물 및 이를 이용한 글루탐산의 제조방법에 관한 것으로, 좀더 상세하게는 코리네박테리움 글루타미컴 (Corynebacterium glutamicum) KFCC-10656의 변이주로서 모노플루오로아세테이트(monofluoroacetate) 내성을 보유하며 이에 따른 대사경로상의 변화에 의해 기존 균주에 비해 글루탐산의 생산능력이 향상된 미생물 및 이를 이용한 글루탐산의 제조방법에 관한 것이다.The present invention relates to a microorganism that produces glutamic acid and a method for producing glutamic acid using the same, and more particularly, has a monofluoroacetate resistance as a mutant of Corynebacterium glutamicum KFCC-10656. The present invention relates to a microorganism having improved production capacity of glutamic acid, and a method for producing glutamic acid using the same, by the metabolic pathway.
글루탐산 생성 대사 경로에서는 시트르산 회로가 대사 전구 물질들의 공급원으로서 중요한 역할을 하는 것으로 알려져 있다. 즉, 글루탐산의 선구 물질인 α-케토글루타르산의 공급은 시트르산 회로의 순환에 의해 이루어지며, 따라서 원활한 시트르산 회로의 순환이 이루어질 때 글루탐산 생성에 유리하다. 시트르산 회로는아세틸-CoA와 옥살로아세트산의 반응에 의해 시트르산이 생성되는 것으로부터 시작된다. 아세틸-CoA는 아세트산으로부터 생화학적 반응에 의해 쉽게 생성되며, 따라서 아세트산 자화성이 높은 균주를 얻는 것은 시트르산 회로를 강화한다는 측면에서 글루탐산 생산에 유리하게 작용할 것으로 생각된다.In the glutamic acid production metabolic pathway, the citric acid cycle is known to play an important role as a source of metabolic precursors. That is, the supply of α-ketoglutaric acid, a precursor of glutamic acid, is made by the circulation of the citric acid cycle, and thus is advantageous for the production of glutamic acid when the smooth circulation of the citric acid cycle occurs. The citric acid cycle starts with the production of citric acid by the reaction of acetyl-CoA with oxaloacetic acid. Acetyl-CoA is easily produced from acetic acid by biochemical reactions, thus obtaining a high acetic acid magnetizable strain would be advantageous for glutamic acid production in terms of enhancing the citric acid cycle.
그러나, 미생물의 대사 과정에는 과량의 대사 산물이 생성되는 것을 억제하는 기작으로서 대사 산물 저해라는 기구가 존재하므로 과량의 중간 대사 산물이 생성 또는 축적 이용되게 하는 것은 쉽지 않다. 즉, 각 대사의 단계에서 생성되는 산물들은 그 대사 산물을 생성하는데 관여하는 효소의 활성을 저해해서 필요 이상으로 대사 산물이 생성, 축적되는 것을 방지한다.However, since a mechanism called metabolite inhibition exists as a mechanism for inhibiting the production of excess metabolites in the metabolic process of microorganisms, it is not easy to allow the formation or accumulation of excess intermediate metabolites. That is, products produced at each metabolic step inhibit the activity of enzymes involved in producing the metabolites, thereby preventing the metabolites from being produced and accumulated more than necessary.
인위적으로 이러한 조절 기구를 해제하는 기존의 방법으로서 특정 대사산물의 유사체에 대한 내성을 지닌 미생물 균주를 획득하는 방법이 통용되어 왔다.As an existing method of artificially releasing such a regulatory mechanism, a method of obtaining a microbial strain resistant to an analog of a specific metabolite has been commonly used.
본 발명자들은 아세트산 유사체에 대한 내성을 지니고 아세트산 자화성이 높은 균주를 얻기 위해 아세트산 유사체인 모노플루오로아세테이트에 내성을 가진 균주를 선별하여 본 발명을 완성하였다.The present inventors completed the present invention by selecting strains resistant to acetic acid analogs and resistant to acetic acid analog monofluoroacetate in order to obtain a strain having high acetic acid magnetization.
본 발명의 미생물 TS1은 코리네박테리움 글루타미컴 KFCC 10656을 모균주로 하여 자외선조사, N-메틸-N`-니트로-N-니트로소구아니딘 (NTG) 등의 변이 유발제로 통상적인 방법에 따라 처리한 후, 모노플루오로아세테이트가 농도별로 첨가된 배지[포도당 10 g/l, 인산제1칼륨 1 g/l, 인산제2칼륨 0.5 g/l, 황산암모늄 0.5 g/l, 요소 1 g/l, 황산철 20 mg/l, 황산마그네슘 0.5 g/l, 황산망간 20 mg/l, 티아민염산염 200 ㎍/l, 비오틴 200 ㎍/l, 당밀 5 g/l, pH 7.0로 이루어진 최소배지에 모노플루오로아세테이트 30-150 g/l을 첨가한 배지]에서 생육할 수 있는 변이주들 중에서 선별된 균주이다. 이때 실험에 사용된 배지중의 모노플루오로아세테이트 농도는 150 g/l까지였으며 분리에 성공한 내성변이주는 70 g/l 모노플루오로아세테이트 농도에서 생육가능한 것으로 확인되었다.Microorganism TS1 of the present invention is a parent strain using Corynebacterium glutamicum KFCC 10656 as a parent strain and according to a conventional method as a mutation inducing agent such as UV irradiation, N-methyl-N`-nitro-N-nitrosoguanidine (NTG), etc. After treatment, the medium to which monofluoroacetate was added [concentration 10g / l glucose, 1g / l potassium phosphate, 0.5g / l potassium diphosphate, 0.5g / l ammonium sulfate, 1g / urea] l, 20 mg / l iron sulfate, 0.5 g / l magnesium sulfate, 20 mg / l manganese sulfate, 200 μg / l thiamine hydrochloride, 200 μg l biotin, 5 g / l molasses, pH 7.0 Medium from which 30-150 g / l of fluoroacetate was added]. At this time, the monofluoroacetate concentration in the medium used for the experiment was up to 150 g / l, and the resistant mutants which were successfully separated were found to be able to grow at 70 g / l monofluoroacetate concentration.
여기서 얻어진 변이주에 대해 플라스크 실험 및 발효조 배양 실험을 실시한 결과 기존 균주에 비해 글루탐산 생산성이 약 11% 정도 향상된 사실이 입증되었으며, 이 균주를 TS1이라 명명하여 1999년 11월 2일에 수탁번호 KFCC-11113으로 한국종균협회에 기탁하였다.Flask experiments and fermenter culture experiments were performed on the mutant strains obtained therein, and it was demonstrated that glutamic acid productivity was improved by about 11% compared to the existing strain.The strain was named TS1 and was assigned accession number KFCC-11113 on November 2, 1999. It was deposited with the Korean spawn association.
본 발명의 균주를 위해 사용된 영양배지는 펩톤 1, 육즙 1, 염화나트륨 0.25, 효모엑기스 1, 한천 2, pH 7.2로 구성된다.The nutrient medium used for the strain of the present invention is composed of peptone 1, gravy 1, sodium chloride 0.25, yeast extract 1, agar 2, pH 7.2.
본 발명에서 분리한 신규 변이주 TS1의 생화학적 특성은 표1 및 표2의 기재와 같으며, 이들 내용에 의하면 본 발명의 미생물은 70 g/l농도의 모노플루오로아세테이트 첨가배지에서도 생육가능하며, 기존 균주에 비해 아세트산 자화성[아세트산 자화성 실험용 배지: 아세트산 10-100 g/l, 인산제1칼륨 1 g/l, 인산제2칼륨 0.5 g/l, 황산암모늄 0.5 g/l, 요소 1 g/l, 황산철 20 mg/l, 황산마그네슘 0.5 g/l, 황산망간 20 mg/l, 티아민염산염 200 ㎍/l, 비오틴 200 ㎍/l, 당밀 5 g/l, pH 7.0]이 향상된 균주임을 알 수 있다.The biochemical properties of the novel mutant TS1 isolated from the present invention are as described in Table 1 and Table 2. According to these contents, the microorganism of the present invention can be grown even in a medium containing 70 g / l monofluoroacetate, Acetic acid magnetization [acetic acid magnetization experimental medium: 10-100 g / l acetic acid, 1 g / l potassium phosphate, 0.5 g / l dibasic potassium phosphate, 0.5 g / l ammonium sulfate, 1 g of urea / l, iron sulfate 20 mg / l, magnesium sulfate 0.5 g / l, manganese sulfate 20 mg / l, thiamine hydrochloride 200 μg / l, biotin 200 μg / l, molasses 5 g / l, pH 7.0]. Able to know.
본 발명 미생물의 특성은 다음의 표에 기재된 바와 같다.The characteristics of the microorganism of the present invention are as described in the following table.
(주) +; 생육, -; 생육하지 못함, 30℃에서 72시간 배양.(Note) +; Growth,-; Not grown, incubated for 72 hours at 30 ° C.
(주) +; 생육, -; 생육하지 못함, 30℃에서 72시간 배양.(Note) +; Growth,-; Not grown, incubated for 72 hours at 30 ° C.
다음의 실시예에서 본 발명을 좀 더 구체적으로 설명한다.The present invention is explained in more detail in the following examples.
실시예 1Example 1
사용균주: 코리네박테리움 글루타미컴 KFCC-10656 및 이의 변이주인 본 발명의 미생물 TS1(KFCC-11113).Use strain: Corynebacterium glutamicum KFCC-10656 and its strain microorganism TS1 (KFCC-11113).
종배지: 펩톤 1, 효모엑기스 0.5, 육즙 0.5, 포도당 1, 염화나트륨 0.25, 요소 0.13, pH 7.2.Species medium: peptone 1, yeast extract 0.5, gravy 0.5, glucose 1, sodium chloride 0.25, urea 0.13, pH 7.2.
발효배지: 포도당 3, 미액 0.2, 비오틴 1 ㎍/l, 폐당밀 0.05, 황산암모늄 0.1, 황산철 0.002, 황산 망간 0.002, 황산 마그네슘 0.05, 티아민 염산염 200 ㎍/l, 인산 제1칼륨 0.2, 요소 0.95, pH 7.2.Fermentation medium: glucose 3, liquid 0.2, biotin 1 μg / l, waste molasses 0.05, ammonium sulfate 0.1, iron sulfate 0.002, manganese sulfate 0.002, magnesium sulfate 0.05, thiamine hydrochloride 200 μg / l, potassium phosphate 0.2, urea 0.95 , pH 7.2.
발효방법: 상기 종배지 3 ml을 지름 18 mm 시험관에 분주하고 상법에 따라 가압 살균후 사용 균주를 접종하고 30℃에서 18시간 진탕 배양하여 종배양액으로 사용하였다. 발효배지 40 ml을 500 ml 진탕용 삼각플라스크에 분주하고 121℃에서 10분간 가압 살균하여 종배양액 1 ml을 식균한 다음 48시간동안 배양하였다. 회전수는 분당 180회, 30℃, pH 7.2로 조절하였다. 배양완료 후, 배지내 글루탐산 축적량은 KFCC-10656이 16.8 g/l, TS1이 18.7 g/l이었다.Fermentation method: 3 ml of the seed medium was dispensed into a test tube with a diameter of 18 mm, inoculated using strain after autoclaving according to a conventional method, and shaken for 18 hours at 30 ° C. to use as a seed culture solution. 40 ml of the fermentation broth was dispensed into a 500 ml shake flask for pressure and sterilized under pressure at 121 ° C. for 10 minutes to inoculate 1 ml of the seed culture solution and incubated for 48 hours. The rotation speed was adjusted to 180 times per minute, 30 ° C., pH 7.2. After incubation, the amount of glutamic acid in the medium was 16.8 g / l for KFCC-10656 and 18.7 g / l for TS1.
본 실시예의 결과, 본 발명의 미생물은 기존 균주에 비해 당 농도 3배지에서 글루탐산 생산성이 약 11정도 향상된 것으로 확인되었다.As a result of the present Example, the microorganism of the present invention was confirmed that the productivity of glutamic acid improved by about 11 at 3 times the concentration of sugar compared to the existing strain.
실시예 2Example 2
사용균주: 실시예 1과 동일Strains used: same as Example 1
1차 종배지: 펩톤 1, 효모 엑기스 0.7, 육즙 0.7, 포도당 1, 자당 1, 염화나트륨 0.25, 요소 0.3, 페놀레드 0.001, pH 7.2.Primary species: peptone 1, yeast extract 0.7, gravy 0.7, glucose 1, sucrose 1, sodium chloride 0.25, urea 0.3, phenol red 0.001, pH 7.2.
2차 종배지: 원당 3, 포도당 1, 과당 1, 황산 마그네슘 0.04, 인산 제1칼륨 0.1, 인산 제2칼륨 0.05, 황산 암모늄 0.8, 황산철 0.002, 황산망간 0.002, 황산아연 0.0002, 황산구리 0.0002, 비오틴 500 ㎍/l, 티아민 염산염 2 mg/l, 대두단백 가수분해물 0.2, 페놀레드 0.001, pH 6.8.Secondary species: raw sugar 3, glucose 1, fructose 1, magnesium sulfate 0.04, potassium monophosphate 0.1, dipotassium phosphate 0.05, ammonium sulfate 0.8, iron sulfate 0.002, manganese sulfate 0.002, zinc sulfate 0.0002, copper sulfate 0.0002, biotin 500 μg / l, thiamine hydrochloride 2 mg / l, soy protein hydrolyzate 0.2, phenol red 0.001, pH 6.8.
발효배지: 자당 6, 포도당 2, 과당 2, 황산 마그네슘 0.05, 인산 제1칼륨 0.05, 인산 제2칼륨 0.15, 황산 암모늄 0.1, 황산철 0.002, 황산망간 0.002, 황산아연 0.0002, 황산구리 0.0002, 비오틴 30 ㎍/l, 티아민 염산염 1 mg/l, 대두단백 가수분해물 0.2, 페놀레드 0.001, 탄산칼슘 3, pH 6.75.Fermentation medium: Sucrose 6, Glucose 2, Fructose 2, Magnesium sulfate 0.05, Potassium phosphate 0.05, Dipotassium phosphate 0.15, Ammonium sulfate 0.1, Iron sulfate 0.002, Manganese sulfate 0.002, Zinc sulfate 0.0002, Copper sulfate 0.0002, Biotin 30 ㎍ / l, thiamine hydrochloride 1 mg / l, soy protein hydrolyzate 0.2, phenol red 0.001, calcium carbonate 3, pH 6.75.
1차 종배양: 상기 1차 종배양 배지 2.5 ml을 18 mm 시험관에 분주하고 121℃에서 5분간 가압 살균하여 냉각한 후 사용균주를 접종하고 30℃에서 분당 160회의 회전수로 12시간 진탕 배양하였다.Primary seed culture: 2.5 ml of the primary seed culture medium was dispensed into an 18 mm test tube, cooled by autoclaving at 121 ° C. for 5 minutes, inoculated with the strain used, and incubated for 12 hours at 30 ° C. at 160 revolutions per minute. .
2차 종배양: 2차 종배지 30 ml을 250 ml 진탕용 삼각플라스크에 분주하고 121℃에서 5분간 가압 살균하여 냉각하고, 1차 종배양액의 배양완료액을 1 ml 접종한 후 31℃에서 150 rpm으로 14시간 진탕 배양하였다.Secondary seed culture: 30 ml of secondary seed medium is dispensed into a 250 ml shake Erlenmeyer flask, pressurized and sterilized at 121 ° C. for 5 minutes, inoculated with 1 ml of the primary seed culture culture solution, and then inoculated with 150 ml at 31 ° C. Shake culture was performed for 14 hours at rpm.
발효방법: 상기 발효배지를 250 ml 삼각 플라스크에 30 ml씩 분주하고, 10요소 용액 1 ml을 첨가한 후 2차 종배양액 5 ml을 접종한 후 31℃에서 150 rpm으로 36시간 배양하였다. 배양 중간에 pH에 따라 10요소수용액 8 ml을 수시로 첨가하여, pH 조절 및 질소원을 공급하였다. 발효시작 2시간 후 계면 활성제 0.04와 페니실린 0.3 U/ml을 첨가하고 당이 모두 소모될 때까지 배양하였다.Fermentation method: The fermentation broth was dispensed 30 ml each in a 250 ml Erlenmeyer flask, 1 ml of 10 urea solution was added and 5 ml of the secondary seed culture solution was inoculated and incubated at 31 ° C. for 150 hours at 150 rpm. In the middle of the culture, 8 ml of 10 urea aqueous solution was added from time to time according to the pH to adjust the pH and supply a nitrogen source. After 2 hours of fermentation, 0.04 of surfactant and 0.3 U / ml of penicillin were added and incubated until all of the sugar was consumed.
배양완료 후 글루탐산의 농도는 KFCC-10656이 45.7 g/l, TS1이 51.9 g/l였다.After incubation, the concentration of glutamic acid was 45.7 g / l for KFCC-10656 and 51.9 g / l for TS1.
실시예 3Example 3
1차 종배지: 펩톤 0.7, 효모엑기스 0.7, 육즙 0.7, 포도당 1, 염화나트륨 0.25, 요소 0.13, 황산 암모늄 0.1, pH 7.5.Primary species: peptone 0.7, yeast extract 0.7, gravy 0.7, glucose 1, sodium chloride 0.25, urea 0.13, ammonium sulfate 0.1, pH 7.5.
2차 종배지: 원당 3, 당밀 1, 황산마그네슘 0.04, 인산제2칼륨 0.1, 황산 암모늄 0.3, 황산철 0.001, 황산망간 0.001, 비오틴 500 ㎍/l, 티아민 염산염 2 mg/l, 요소 0.1, pH 7.1.Secondary species: raw sugar 3, molasses 1, magnesium sulfate 0.04, potassium diphosphate 0.1, ammonium sulfate 0.3, iron sulfate 0.001, manganese sulfate 0.001, biotin 500 μg / l, thiamine hydrochloride 2 mg / l, urea 0.1, pH 7.1.
발효배지: 원당 1.7, 당밀 6.8, 인산 0.13, 황산마그네슘 0.04, 황산철 0.001, 황산망간 0.001, 미액 0.1, 티아민 염산염 200 ㎍/l, 수산화칼륨 0.18, 소포제 0.005, pH 7.5.Fermentation medium: raw sugar 1.7, molasses 6.8, phosphoric acid 0.13, magnesium sulfate 0.04, iron sulfate 0.001, manganese sulfate 0.001, fine liquid 0.1, thiamine hydrochloride 200 μg / l, potassium hydroxide 0.18, antifoam 0.005, pH 7.5.
1차 종배양: 1차 종배지 40 ml을 500 ml 진탕용 삼각 플라스크에 분주하고 121℃에서 10분간 가압 살균하여 냉각 후 균주를 접종하여 회전수 분당 180회, 30℃에서 20시간 진탕 배양하였다.Primary seed culture: 40 ml of the primary seed medium was dispensed into a 500 ml shake Erlenmeyer flask, pressurized and sterilized at 121 ° C. for 10 minutes, inoculated with the strain, cooled, and incubated at 180 revolutions per minute and 20 ° C. for 20 hours.
2차 종배양: 2차 종배지를 5리터 용량의 실험용 발효조에 2.5리터씩 분주하고 121℃에서 10분간 가압 살균한 후 냉각시켜 1차 종배양액의 배양완료액을 30 ml 접종한 후 공기를 분당 0.5리터 공급하면서 900 rpm, 30℃에서 18시간 진탕 배양하였다.Secondary seed culture: Dispense the secondary seed medium into 2.5 liters of each fermenter for 5 liters, pressurize and sterilize at 121 ℃ for 10 minutes, cool, inoculate 30 ml of the primary seed culture culture solution, and air Shaking culture was carried out for 18 hours at 900 rpm, 30 ℃ while feeding 0.5 liter.
발효방법: 상기 발효배지를 30리터 용량의 시험발효조에 9리터씩 분주하고 121℃에서 10분간 가압 살균한 뒤 냉각하여 2차 종배양액을 약 1.5리터씩 접종한 후, 공기를 매분당 2.5리터씩 공급하면서 450 rpm, 31℃에서 배양하였다.Fermentation method: Dispense the fermentation broth into a 30 liter test fermentation tank at 9 liters, sterilize for 10 minutes at 121 ° C, cool, inoculate 1.5 liters of secondary culture medium, and 2.5 liters of air per minute. Incubation was performed at 450 rpm and 31 ° C. while feeding.
상기 조건으로 배양하여 대수증식기 초기 내지 말기 사이에 페니실린 혹은 계면활성제를 첨가하고 배양하며 배양중 발효액의 pH는 28암모니아수로 pH 7.7이 되도록 계속 조절하였다. 배양중 잔당의 농도가 1.5가 되면 살균된 폐당밀 또는 폐당밀과 원당을 일정한 비율로 혼합한 당을 수시로 공급하였다. 추가로 당밀 또는 혼합당과의 초기의 발효배지에 첨가된 당의 합계가 발효액량 대비 22가 될 때까지 계속 배양하였다. 배양완료 후 글루탐산의 농도는 KFCC-10656이 109.6 g/l, TS1이 121.1 g/l이었다.The culture was carried out under the above conditions, and then penicillin or a surfactant was added between the early and the end of the logarithmic growth period, and the pH of the fermentation broth was continuously adjusted to pH 7.7 with 28 ammonia water. When the concentration of the residual sugar in the culture was 1.5, the sterile pulmonary molasses or a mixture of the waste molasses and the raw sugars was supplied at regular ratios. Further culture was continued until the sum of the sugars added to the initial fermentation medium with molasses or mixed sugar was 22 relative to the amount of fermentation broth. After incubation, the concentration of glutamic acid was 109.6 g / l for KFCC-10656 and 121.1 g / l for TS1.
본 발명에 따른 코리네박테리움 글루타미컴 TS1은 글루탐산 생산능이 향상된 균주로서 이를 폐당밀, 포도당, 전분 가수분해물 및 원당 등이 포함된 배지에서 배양하여 글루탐산을 고수율로 제조할 수 있다.Corynebacterium glutamicum TS1 according to the present invention can be produced in high yield by culturing in a medium containing glutamate, glucose, starch hydrolyzate and raw sugar as an improved glutamic acid production capacity.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990053494A KR100317901B1 (en) | 1999-11-29 | 1999-11-29 | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990053494A KR100317901B1 (en) | 1999-11-29 | 1999-11-29 | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010048696A KR20010048696A (en) | 2001-06-15 |
KR100317901B1 true KR100317901B1 (en) | 2001-12-24 |
Family
ID=19622409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990053494A KR100317901B1 (en) | 1999-11-29 | 1999-11-29 | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100317901B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101138289B1 (en) * | 2009-09-29 | 2012-04-24 | 대상 주식회사 | Microorganism having glutamic acid-producing activity and process for producing glutamic acid using the same |
KR101433599B1 (en) * | 2011-11-10 | 2014-08-27 | 씨제이제일제당(주) | The flavor containing L-glutamic acid and method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230053545A (en) * | 2022-12-30 | 2023-04-21 | 씨제이제일제당 (주) | Microorganisms with enhanced L-alanine productivity and method for producing L-alanine using the same |
-
1999
- 1999-11-29 KR KR1019990053494A patent/KR100317901B1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101138289B1 (en) * | 2009-09-29 | 2012-04-24 | 대상 주식회사 | Microorganism having glutamic acid-producing activity and process for producing glutamic acid using the same |
KR101433599B1 (en) * | 2011-11-10 | 2014-08-27 | 씨제이제일제당(주) | The flavor containing L-glutamic acid and method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20010048696A (en) | 2001-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101117022B1 (en) | A microorganism having enhanced l-valine production and process for preparing l-valine using the same | |
KR100292299B1 (en) | Microorganism producing glutamic acid and process for preparation glutamic acid using the same | |
EP0745679B1 (en) | A method for producing L-isoleucine with a fermentation process and L-homoserine as the sole nitrogen source | |
KR100317901B1 (en) | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism | |
KR100264740B1 (en) | A microorganism producing glutamic acid and a producing method of the glutamic acid using the same | |
KR100317902B1 (en) | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism | |
US7456010B2 (en) | Microorganism producing 5′-xanthylic acid | |
KR20020057470A (en) | A microorganism Corynebacterium ammoniagenes NV4-82-9 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same | |
US6133000A (en) | Fermentative preparation of amino acids | |
KR100292298B1 (en) | Microorganism producing glutamic acid and process for preparation glutamic acid using the same | |
US7217558B2 (en) | Microorganism producing 5'xanthylic acid | |
KR100264741B1 (en) | A microorganism producing glutamic acid and a producing method of the glutamic acid using the same | |
KR900007948B1 (en) | Novel microorganism for producing of glutamic acid | |
KR100376537B1 (en) | Microorganism Corynebacterium glutamicum producing L-lysine and process for producing L-lysine by use thereof | |
US20060270004A1 (en) | Fermentation processes with low concentrations of carbon-and nitrogen-containing nutrients | |
Igarashi et al. | Excretion of L-tryptophan by analogue-resistant mutants of Pseudomonas hydrogenothermophila TH-1 in autotrophic cultures | |
KR900007946B1 (en) | Novel microorganism for producing of glutamic acid | |
KR900007947B1 (en) | Novel microorganism for producing of glutamic acid | |
KR0146493B1 (en) | Process for producing l-alanine by fermentation | |
KR900007945B1 (en) | Novel microorganism for producing of glutamic acid | |
KR900007938B1 (en) | Novel microorganism for producing of glutamic acid | |
KR100205797B1 (en) | Microorganism producing glutamic acid and process for preparing glutamic acid using the same | |
KR100446110B1 (en) | Cephalosporin c-producing microorganism having tolerance against high concentration of glycerol | |
KR950007222B1 (en) | Production of l-leucine by microorganism cultivation | |
KR900007940B1 (en) | Novel microorganism for producing of glutamic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20081001 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |